InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,228.24
(
0.27%
)
US TECH 100
17,751.20
(
0.63%
)
Dow Jones
39,501.01
(
0.29%
)
Brent Oil
83.96
(
0.01%
)
Bitcoin
62,726.23
(
-0.51%
)
Post# of 477
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

nightwish

Send PM Follow Ignore
Followers 16
Posts 839
Boards Moderated 0
Alias Born 12/18/2007

nightwish

Re: None

Friday, 01/14/2011 11:16:45 AM

Friday, January 14, 2011 11:16:45 AM

Post# of 477
MIV Therapeutic´s VESTASYNC stent

http://www.faqs.org/patents/app/20110008232

"[0006]While extensively used in the hard tissue arena, the use of HAP as an alternative to polymers in drug delivery systems relevant to cardiovascular medical devices is currently under development for example MIV therapeutics VESTASYNC.TM. stent. Results recently reported on the clinical trial underway by MIV Therapeutics demonstrate no adverse clinical effects from the use of HAP-coated coronary stents.sup.(6)."

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up